Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,681 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Ireland is courting U.S. firms with a wave of investment deals announced during a Washington visit, signaling a conti...
Arizona regulators filed a 20-count complaint alleging Kalshi engaged in illegal gambling and election wagering. The ...
The U.S.-led airstrike on Iran sent markets into a tailspin, with oil surging and stock indexes dropping. As policyma...
Disney moved to strengthen its finances ahead of a CEO transition by extending CFO Hugh Johnston's contract, signalin...
A new $150 million startup thinks real world connection can counter online detachment. This report examines the plan,...
A trio of XRP ETFs began trading in 2026, offering exposure to XRP without direct coin ownership. This piece reviews ...
The European Union and Mercosur clinched a landmark free-trade agreement after 25 years of negotiations, linking 700 ...
Medicare is tightening oversight on hospice providers amid rising admissions and fraud concerns. The crackdown could ...
Epic Games cuts 1,000 jobs as Fortnite engagement wanes in a challenging market. The move highlights how live-service...
The OpenAI Foundation announced a $1 billion grant program over the next year to help retrain workers, support mental...
Oil prices surge on geopolitical tensions, lifting energy stocks. This article examines a single ETF that could benef...